Flavonoids regulating NLRP3 inflammasome: a promising approach in alleviating diabetic peripheral neuropathy
Open Access
- 9 April 2025
- journal article
- review article
- Published by Springer Nature in Inflammopharmacology
- Vol. 33 (5) , 2231-2262
Abstract
A common and serious side effect of diabetes is diabetic peripheral neuropathy (DPN), which is characterised by gradual nerve damage brought on by oxidative stress, chronic inflammation, and prolonged hyperglycemia. Studies identify NLRP3 inflammasome as a key mediator in the pathogenesis of DPN, connecting neuroinflammation and neuronal damage to metabolic failure. Because of their strong anti-inflammatory and antioxidant qualities, flavonoids, a broad class of naturally occurring polyphenols, have drawn interest as potential treatments for DPN. The various ways that flavonoids affect the NLRP3 inflammasome and their potential as a treatment for DPN are examined in this review. It has been demonstrated that flavonoids prevent NLRP3 activation, which lowers the release of pro-inflammatory cytokines including IL-1β and IL-18 and causes neuroinflammation. Flavonoids work mechanistically by reducing oxidative stress, altering important signalling pathways, and blocking the activities of NF-κB and caspase-1, which are both essential for the activation of the NLRP3 inflammasome. Preclinical research has shown that flavonoids have strong neuroprotective benefits, and few clinical evidence also points to the potential of flavonoids to improve nerve function and lessen neuropathic pain in diabetic patients. The current review emphasises how flavonoids may be used as a treatment strategy to target inflammation in DPN caused by the NLRP3 inflammasome. By targeting important inflammatory pathways, flavonoids provide a new way to slow the progression of this debilitating illness. Further investigation into the mechanisms, clinical translation, and novel drug delivery techniques could enhance the therapeutic efficacy of diabetic peripheral neuropathy. Graphical abstractKeywords
Funding Information
- Manipal Academy of Higher Education, Manipal
This publication has 214 references indexed in Scilit:
- Potential of Flavonoids as Anti-inflammatory Agents: Modulation of Pro- Inflammatory Gene Expression and Signal Transduction PathwaysCurrent Drug Metabolism, 2009
- Luteolin, a Flavonoid with Potential for Cancer Prevention and TherapyCurrent Cancer Drug Targets, 2008
- The RAGE PathwayAnnals of the New York Academy of Sciences, 2008
- Pathology and pathogenetic mechanisms of diabetic neuropathy: Correlation with clinical signs and symptomsDiabetes Research and Clinical Practice, 2007
- Polyphenols, intracellular signalling and inflammation.2007
- Diabetic neuropathy and oxidative stressDiabetes/Metabolism Research and Reviews, 2006
- In vivo quercitrin anti‐inflammatory effect involves release of quercetin, which inhibits inflammation through down‐regulation of the NF‐κB pathwayEuropean Journal of Immunology, 2005
- Molecular Targets of Dietary Polyphenols with Anti-inflammatory PropertiesYonsei Medical Journal, 2005
- Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic painProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2003
- Inhibition of matrix-proteases by polyphenols: chemical insights for anti-inflammatory and anti-invasion drug designBiochemical Pharmacology, 2002